Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Global Artificial Intelligence (AI) in Oncology Market Size study, by Treatment (Hemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy, And Others) by Type (Lung Cancer, Breast Cancer, Melanoma Cancer, Prostate Cancer, Colorectal Cancer, Among Others), by Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028
... Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028 Global Artificial Intelligence (AI) in Oncology Market is valued at approximately USD XX Million in 2021 and is anticipated to grow with a healthy ... Read More
-
Custom Antibody Service Market, by Service Type (Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)), by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, ... Read More
-
Asia-Pacific Colorectal Cancer Market to 2028 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... is expected to grow from US$ 3,864.66 million in 2022 to US$ 5,169.04 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028. The growing pharmaceutical industry in ... Read More
-
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Peripheral T-Cell Lymphomas (PTCL) Clinical trials scenario. This report provides top line data ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer ... Read More
-
Asia Pacific Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The APAC human ... Read More
-
Europe Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The Europe human papillomavirus ... Read More
-
Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
South America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others) The South America ... Read More
-
Middle East & Africa Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The ... Read More
-
North America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-Valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others) The North America ... Read More
-
North America Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... America is expected to grow from US$ 8,559.27 million in 2022 to US$ 11,198.11 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028. Colorectal cancer is one ... Read More
-
Digital Marketing Trends in Hepatocellular Carcinoma
... by Bristol Myers Squibb's (BMS’s) Opdivo.com (1.2 million visits) and Genentech's Tecentriq.com (497,000 visits). The highest proportion of traffic to these sites originated from direct sources, followed by organic and referral traffic. Between August 2021 ... Read More
-
Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... expected to grow from US$ 4,627.82 million in 2022 to US$ 5,819.96 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2022 to 2028. The market for colorectal cancer is ... Read More
-
Cytokine Market, By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF, and Other Cytokine Types), By Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cytokines are a category of small proteins important in cell signaling. They are small proteins that ... Read More
-
Blood Testing Market Size By Test Type (Complete Blood Count Test, Kidney Test- Renal Profile, Cholesterol Test- Lipid Profile Test, Blood Glucose Test, Antibodies Test - Rheumatoid Factor, Urine Test, Infectious Disease Screening, Cancer Test, Heart Test), By Product (Instruments, Reagents & Kits, Software), By Method (Manual, Automated), By End-use (Hospitals, Pathology Labs, Blood Banks, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Heart Test), By Product (Instruments, Reagents & Kits, Software), By Method (Manual, Automated), By End-use (Hospitals, Pathology Labs, Blood Banks, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 ... Read More
-
Global mRNA therapeutics Market Size study, by Application (Rare genetic diseases, Oncology, Respiratory diseases, Infectious disease and others), By Type (Prophylactic Vaccines, Therapeutic Vaccines and Therapeutic Drugs), By End-User (Hospitals & Clinics, Research Organizations and Others) and Regional Forecasts 2022-2028
... Others) and Regional Forecasts 2022-2028 Global mRNA therapeutics Market is valued at approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the ... Read More
-
Global Mobile Computed Tomography Scanners Market Size study, by Technology (High, Mid, Low Slice), by Application (Orthopedics, Cardiovascular, Oncology, Neurology, Others), by End-User (Hospitals, Diagnostics & Imaging Centers, Research Academics) and Regional Forecasts 2022-2028
... Mobile Computed Tomography Scanners Market is valued at approximately XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2022-2028. A mobile CT ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
Cancer Biomarkers Market (Type: Protein, Genetics, and Others; and Type of Cancer: Lung, Breast, Leukemia, Melanoma, Colorectal, Prostate, Ovarian, Liver, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Market – Scope of Report TMR’s report on the global cancer biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Oncology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $26.0 and in terms of global GDP, the market was 0.23%. Oncology drugs was the second largest segment within the market accounting for 13.7% preceded and followed by anti-infective drugs ... Read More
-
Hematology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $4.2 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.7% ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than one million incidence cases of HER2- BC across 16 pharmaceutical markets. There are several marketed innovator drugs for the treatment of HER2- BC, mostly kinase inhibitors. A total of seven ... Read More
-
Global Cancer Biomarkers Market Opportunity Analysis and Industry Forecast till 2031: By Biomarker Type (Protein Biomarker, Genetic Biomarker, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others), By Profiling Technologies (Omics Technology, Imaging Technologies, Immunoassays, Bioinformatics, Cytogenetics), By Application (Diagnostics, Research & Development, Prognostics, Risk Assessments, Others); and By Region
... (Omics Technology, Imaging Technologies, Immunoassays, Bioinformatics, Cytogenetics), By Application (Diagnostics, Research & Development, Prognostics, Risk Assessments, Others); and By Region The global cancer biomarkers market size was USD 13.4 billion in 2021 and it is ... Read More
-
Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, Gene Transfer); By End-Use (Research Institutes, Biopharma Companies); By Region; Segment Forecast, 2022 - 2030
... size is expected to reach USD 3.99 billion by 2030, according to a new study by Polaris Market Research. The report “Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, ... Read More
Research Assistance
